H.R. 3348 — Introduced in House

I 115th CONGRESS 1st Session H. R. 3348 IN THE HOUSE OF REPRESENTATIVES July 20, 2017Mr. Peters (for himself, Mr. Brendan F. Boyle of Pennsylvania, Mr. Marshall, and Mr. Rothfus) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To expand the tropical disease product priority review voucher program to encourage treatments for the Middle East respiratory syndrome. 1. Short title This Act may be cited as the Adding Middle East Respiratory Syndrome to the FDA Priority Review Voucher Program Act. 2. Expanding tropical disease product priority review voucher program to encourage treatments for Middle East respiratory syndrome Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n(a)(3)) is amended— (1) by redesignating subparagraph (S) as subparagraph (T); and (2) by inserting after subparagraph (R) the following: (S) Middle East respiratory syndrome. .